Literature DB >> 10825000

A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.

M I Shuster1, L Han, M M Le Beau, E Davis, M Sawicki, C M Lese, N H Park, J Colicelli, S M Gollin.   

Abstract

Gene amplification is a common feature of tumors. Overexpression of some amplified genes plays a role in tumor progression. Gene amplification can occur either extrachromosomally as double-minute chromosomes (dmin) or intrachromosomally in the form of homogeneously staining regions (hsrs). Approximately one-half of our oral squamous cell carcinomas (OSCCs) are characterized by amplification of band 11q13, usually as an hsr located entopically (occurring or situated at the normal chromosomal site, as opposed to ectopically). Using chromosomal fluorescence in situ hybridization (FISH), we confirmed the amplification of the cyclin D1 (CCND1/PRAD1) and fibroblast growth factor types 3 and 4 (FGF3/INT2 and FGF4/HSTF1) genes within the 11q13 amplicon in our series of primary OSCCs and derived cell lines. The human RIN1 gene was isolated as an RAS interaction/interference protein in a genetic selection in yeast and has been described as a putative effector of both the RAS and ABL oncogenes. We mapped RIN1 to 11q13.2. FISH analysis of 10 11q13-amplified OSCC cell lines revealed high-level RIN1 amplification in two cell lines. Three additional cell lines have what appear to be duplications and/or low-level amplification of RIN1, visible in both interphase and metaphase cells. The hybridization pattern of RIN1 on the metaphase chromosomes is particularly revealing; RIN1 signals flank the 11q13 hsr, possibly as a result of an inverted duplication. The gene amplification model of Coquelle et al. (1997) predicted that gene amplification occurs by breakage-fusion-bridge (BFB) cycles involving fragile sites. Our data suggest that the pattern of gene amplification at 11q13 in OSCC cell lines is consistent with a BFB model. RIN1 appears to be a valuable probe for investigating the process of gene amplification in general and, specifically, 11q13 amplification in oral cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825000

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  34 in total

1.  SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.

Authors:  Drazen B Zimonjic; Marian E Durkin; Catherine L Keck-Waggoner; Sang-Won Park; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

Review 2.  Emerging roles of SIRT6 on telomere maintenance, DNA repair, metabolism and mammalian aging.

Authors:  Gaoxiang Jia; Ling Su; Sunil Singhal; Xiangguo Liu
Journal:  Mol Cell Biochem       Date:  2012-05       Impact factor: 3.396

3.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

4.  High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.

Authors:  Johan H Gibcus; Klaas Kok; Lorian Menkema; Mario A Hermsen; Mirjam Mastik; Philip M Kluin; Jacqueline E van der Wal; Ed Schuuring
Journal:  Hum Genet       Date:  2006-12-15       Impact factor: 4.132

5.  Assessment of palindromes as platforms for DNA amplification in breast cancer.

Authors:  Jamie Guenthoer; Scott J Diede; Hisashi Tanaka; Xiaoyu Chai; Li Hsu; Stephen J Tapscott; Peggy L Porter
Journal:  Genome Res       Date:  2011-07-13       Impact factor: 9.043

6.  Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.

Authors:  Katja Lundgren; Nicholas P Tobin; Sophie Lehn; Olle Stål; Lisa Rydén; Karin Jirström; Göran Landberg
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

7.  Heterogeneity of 11q13 region rearrangements in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization.

Authors:  Małgorzata Jarmuz-Szymczak; Kinga Pelinska; Magdalena Kostrzewska-Poczekaj; Ewa Bembnista; Maciej Giefing; Damian Brauze; Marcin Szaumkessel; Andrzej Marszalek; Joanna Janiszewska; Katarzyna Kiwerska; Anna Bartochowska; Reidar Grenman; Witold Szyfter; Krzysztof Szyfter
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

8.  Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Authors:  Madhav Sankunny; Rahul A Parikh; Dale W Lewis; William E Gooding; William S Saunders; Susanne M Gollin
Journal:  Genes Chromosomes Cancer       Date:  2013-11-25       Impact factor: 5.006

9.  High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells.

Authors:  Xin Huang; Susanne M Gollin; Siva Raja; Tony E Godfrey
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-09       Impact factor: 11.205

Review 10.  Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome.

Authors:  Hisashi Tanaka; Meng-Chao Yao
Journal:  Nat Rev Cancer       Date:  2009-02-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.